Parpataka (Fumaria indica): Traditional Uses, Evidence & Safety

TL;DR

Parpataka (Fumaria indica), an annual Ayurvedic herb, is the accepted source of the parpataka drug used traditionally for low-grade fevers, liver complaints, and skin disorders. There are no human clinical trials; the only efficacy data come from a rat fever study and laboratory work on its alkaloids. No established human dose exists.

(52 words. Sources: IJCPR 2019 standardization paper; IAMJ rat antipyretic study; IAIM review.)

What it is

Parpataka is the whole plant of Fumaria indica (Hausskn.) Pugsley, an annual, diffuse herb of the fumitory family with small white or pink-purple flowers, confined to India. According to a peer-reviewed standardization paper, the Ayurvedic Formulary of India accepts Fumaria indica as the official botanical source of the parpataka drug (IJCPR standardization paper). (Regional traditions sometimes equate parpataka with other species, e.g. Rungia repens; the accepted source is F. indica per the same paper.) The plant is rich in isoquinoline-type alkaloids, including protopine and cryptopine (IAIM ethnobotanical and pharmacological review).

Traditional use

Classical and folk accounts describe parpataka as bitter and cooling, used in low-grade fevers, to "purify the blood," and in skin disorders. It is sold in Indian bazaars as shahtarah/pitpapra and used for stomach disorders and liver complaints, and in Punjab and North India against fevers (IJCPR standardization paper, introduction). The whole plant is used, commonly as a decoction (kwatha) or cold infusion. These are traditional claims, not clinical proof: the research evidence is assessed separately below.

What modern research says

Fever (animal only)

In an experimental study on albino rats, a Fumaria indica kwatha (decoction) was tested against brewer's-yeast-induced pyrexia, alongside paracetamol as the standard drug. The authors reported an antipyretic effect consistent with parpataka's traditional reputation for fevers (Varshney & Suresh, IAMJ 2015). This is a single small animal study: not evidence that it treats fever in humans.

Liver and antimicrobial work (laboratory)

A peer-reviewed review of Fumaria indica catalogues preclinical reports of hepatoprotective, antimicrobial, antifungal, anti-inflammatory, antioxidant, and antiulcer activity: all from laboratory or animal work, none from human trials (IAIM ethnobotanical and pharmacological review).

What the evidence does not support (yet)

There are no published human clinical trials of Fumaria indica for fever, liver disease, skin disorders, or any other condition. Everything beyond traditional use is preclinical.

Dosage

No human clinical-trial dose exists. The rat antipyretic study dosed its kwatha by converting the classical human dose of 1 pala (48 ml) to a rat equivalent (Varshney & Suresh, IAMJ 2015): a classical reference reported inside a research paper, not a validated modern dosing recommendation. No pharmacopoeial human dose was located in the sources reviewed; do not infer a dose from this article.

Safety & contraindications

No human safety studies of Fumaria indica were found. It is an alkaloid-rich plant, and one of its known alkaloid classes (isoquinolines) includes pharmacologically active compounds: a reason for caution, not a specific danger signal. Avoid during pregnancy and breastfeeding for lack of safety data. Given the absence of human data entirely, parpataka should not be self-dosed; anyone considering it should consult a qualified practitioner.

FAQs

What is parpataka used for?

Traditionally, the whole plant of Fumaria indica is used for low-grade fevers, liver complaints, stomach disorders, and skin conditions, usually as a decoction or cold infusion (IJCPR standardization paper). These are traditional uses, not proven effects.

Is there any clinical evidence for parpataka?

No human trials exist. The only efficacy experiment found was a rat fever study showing an antipyretic effect, plus laboratory work on its alkaloids (Varshney & Suresh, IAMJ 2015; IAIM review).

Is parpataka safe?

Unknown in humans: no safety studies were found. It should be avoided in pregnancy and breastfeeding, and not self-dosed, given the complete absence of human data.

What is the dose of parpataka?

There is no established dose. Classical texts reference a kwatha (decoction) preparation; the one animal study converted a classical 1 pala (48 ml) reference for rats: neither is a modern dosing recommendation (Varshney & Suresh, IAMJ 2015).

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.